Tevogen Bio Inc.
TVGN | NASDAQ
$5.91
+$0.01 (+0.17%)
Nov 2, 2026, 9:30 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 204.98K | 144.84K | 85.79K | 103.55K | 205.29K | 305.28K | 403.58K | 400.9K | 392.74K | 385.45K | 287.15K | 186.28K | 92.7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -204.98K | -144.84K | -85.79K | -103.55K | -205.29K | -305.28K | -403.58K | -400.9K | -392.74K | -385.45K | -287.15K | -186.28K | -92.7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -21.4M | -21.19M | -26.14M | -30.89M | -31.25M | -34.4M | -53.56M | -46.21M | -42.45M | -36.04M | -8.84M | -7.05M | -4.92M | -2.99M | -953.08K | -910.3K | -711.59K | -464.3K | -181.42K | -11.41K | -11.3K |
Interest Income | n/a | n/a | n/a | n/a | n/a | 6 | 6 | 632.8K | 632.8K | 632.8K | 632.8K | 2.74M | 4.48M | 4.81M | 4.95M | 2.22M | 484.53K | 156.7K | 15.81K | n/a | n/a |
Pretax Income | -21.61M | -21.35M | -26.28M | -31.04M | -31.2M | -35.36M | -13.73M | -7.92M | -5.94M | -18.46M | -60.48M | -54.23M | -48.71M | -26.32M | 4.41M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
Net Income | -21.61M | -21.35M | -26.28M | -30.85M | -31.03M | -31.58M | -9.94M | -4.33M | -2.32M | -18.46M | -60.48M | -54.23M | -48.71M | -26.32M | 4.41M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
Selling & General & Admin | 9.77M | 10.13M | 15.03M | 18.95M | 19.05M | 20.68M | 22.23M | 16.8M | 15.19M | 11.88M | 4.15M | 3.36M | 2.45M | 1.65M | 953.08K | 910.3K | 711.59K | 464.3K | 181.42K | 11.41K | 11.3K |
Research & Development | 11.63M | 11.05M | 11.11M | 11.84M | 11.99M | 13.42M | 31.03M | 29.11M | 26.96M | 23.87M | 4.4M | 3.5M | 2.38M | 1.35M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -204.98K | -144.84K | -85.79K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 21.2M | 21.04M | 26.05M | 30.79M | 31.04M | 34.1M | 53.16M | 45.81M | 42.06M | 35.65M | 8.56M | 6.86M | 4.83M | 2.99M | 953.08K | 910.3K | 711.59K | 464.3K | 181.42K | 11.41K | 11.3K |
Interest Expense | 160.24K | 99.88K | 195.62K | 140.74K | 90.86K | 52.83K | 184.04K | 168.25K | 455.73K | 755.62K | 888.83K | 888.83K | 588.88K | 289K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 21.4M | 21.19M | 26.14M | 30.89M | 31.25M | 34.4M | 53.56M | 46.21M | 42.45M | 36.04M | 8.84M | 7.05M | 4.92M | 2.99M | 953.08K | 910.3K | 711.59K | 464.3K | 181.42K | 11.41K | 11.3K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.83M | 3.49M | 3.32M | 3.92M | 3.69M | 3.23M | 3.56M | 3.4M | 3.08M | 2.75M | 3.24M | 3.16M | 2.78M | 2.4M | 958.67K | 958.67K | 958.67K | 958.67K | 958.67K | 929.67K | 929.67K |
Shares Outstanding (Diluted) | 3.83M | 3.49M | 3.32M | 3.92M | 3.69M | 3.23M | 3.56M | 3.4M | 3.08M | 2.85M | 3.24M | 3.16M | 2.78M | 2.4M | 958.67K | 958.67K | 958.67K | 958.67K | 958.67K | 929.67K | 929.67K |
EPS (Basic) | -5.83 | -5.84 | -7.48 | -8.88 | -9.12 | -9.56 | -2.30 | 0.04 | 0.54 | -5.49 | -22.49 | -19.51 | -16.59 | -8.38 | 4.60 | 1.85 | 0.17 | -0.06 | -0.03 | -0.01 | -0.01 |
EPS (Diluted) | -5.83 | -5.84 | -7.48 | -8.88 | -9.12 | -9.56 | -19.30 | -16.96 | -16.46 | -22.49 | -22.49 | -19.51 | -16.59 | -8.38 | 4.60 | 1.85 | 0.17 | -0.06 | -0.03 | -0.01 | -0.01 |
EBITDA | -20.95M | -20.83M | -25.61M | -30.41M | -30.81M | -34.9M | -13.14M | -7.03M | -4.77M | -17M | -58.89M | -52.87M | -47.74M | -25.74M | 4.61M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
EBIT | -21.45M | -21.29M | -26.12M | -30.94M | -31.15M | -35.31M | -13.54M | -7.43M | -5.16M | -17.38M | -59.27M | -53.34M | -48.12M | -26.03M | 4.41M | 1.78M | 163.56K | -54.73K | -28.75K | -11.41K | -11.3K |
Depreciation & Amortization | 496.4K | 462.85K | 509.2K | 526.96K | 337.28K | 410.68K | 403.58K | 400.9K | 392.74K | 385.45K | 378.36K | 473.55K | 382.06K | 289.36K | 198.15K | 2.1K | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TVGN